Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive HF-X
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Skin
DISEASE(S): Melanoma
SUBMITTER: Antje Dittmann
LAB HEAD: Enrique Espinosa
PROVIDER: PXD038155 | Pride | 2023-09-25
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
20190904_004_S202954_GEM003.raw | Raw | |||
20190904_005_S202991_GEM0040.raw | Raw | |||
20190904_006_S203000_GEM0049.raw | Raw | |||
20190904_008_S202955_GEM004.raw | Raw | |||
20190904_009_S202998_GEM0047.raw | Raw |
Items per page: 1 - 5 of 45 |
Cancers 20230903 17
Immunotherapy improves the survival of patients with advanced melanoma, 40% of whom become long-term responders. However, not all patients respond to immunotherapy. Further knowledge of the processes involved in the response and resistance to immunotherapy is still needed. In this study, clinical paraffin samples from fifty-two advanced melanoma patients treated with anti-PD-1 inhibitors were assessed via high-throughput proteomics and RNA-seq. The obtained proteomics and transcriptomics data we ...[more]